A method for the treatment of malignant diseases by inhibiting nucleolin

Details for Australian Patent Application No. 2004279837 (hide)

Owner University of Louisville Research Foundation, Inc.

Inventors Xu, Xiaohua; Miller, Donald M.; Trent, John O.; Bates, Paula J.

Agent Griffith Hack

Pub. Number AU-B-2004279837

PCT Pub. Number WO2005/035579

Priority 10/683,480 09.10.03 US

Filing date 8 October 2004

Wipo publication date 21 April 2005

Acceptance publication date 1 April 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/035579 Priority application(s): WO2005/035579

10 July 2008 Amendment Made

  The nature of the amendment is to Amend the invention title to read: A method for the treatment of malignant diseases by inhibiting nucleolin

1 April 2010 Application Accepted

  Published as AU-B-2004279837

29 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279855-Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups

2004279831-Methods of controlling multilayer foil ignition